Fenofibric Acid Capsule, Delayed Release
Product Images NDC 46708-245

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibric Acid (NDC 46708-245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Fenofibricacid 135mg)

Fenofibric Acid 135 mg delayed-release capsules label, showing the brand and strength prominently. The label includes instructions for pharmacists to dispense the accompanying medication guide, storage conditions, and manufacturer Alembic Pharmaceuticals Limited. It specifies the package contains 30 capsules and has an NDC of 46708-245-30.*

FDA Label Image

30's Bottle Pack (Fenofibricacid 45mg)

Fenofibric Acid Delayed-Release Capsules 45 mg label from Alembic Pharmaceuticals Limited. The oral capsules contain choline fenofibrate equivalent to 45 mg fenofibric acid. The package holds 30 capsules and includes storage instructions and a caution against accepting if seal is broken.*

FDA Label Image

Structure (Fenofibricacid Str)

Chemical structure of fenofibric acid depicted as a molecular diagram showing aromatic rings, a chlorine atom, and other functional groups consistent with fenofibric acid representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.